California Public Employees Retirement System’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-91,736
Closed -$4.28M – 1244
2021
Q4
$4.28M Buy
+91,736
New +$4.65M ﹤0.01% 1177
2021
Q2
– Sell
-43,600
Closed -$1.26M – 2287
2021
Q1
$1.26M Sell
43,600
-5,164
-11% -$141K ﹤0.01% 2326
2020
Q4
$1.37M Sell
48,764
-1,431
-3% -$41.2K ﹤0.01% 2258
2020
Q3
$1.55M Buy
+50,195
New +$1.69M ﹤0.01% 1971

Other funds holding LEGN

California Public Employees Retirement System's LEGN Position: Q1 2022 in Review

California Public Employees Retirement System sold out of Legend Biotech (LEGN) in Q1 2022, closing a stake of 91,736 shares — an estimated $4.28M sold.

California Public Employees Retirement System first reported a position in LEGN in Q3 2020 and held it in 4 quarters. The position peaked at $4.28M in Q4 2021. 141 funds tracked by Wall St. Rank hold LEGN as of Q1 2022.

  • California Public Employees Retirement System reported no remaining Legend Biotech position as of Q1 2022 after selling out during the quarter.
  • California Public Employees Retirement System sold 91,736 Legend Biotech shares in Q1 2022, an estimated $4.28M.
  • California Public Employees Retirement System first reported a position in Legend Biotech in Q3 2020 and held it in 4 quarters.
  • California Public Employees Retirement System's Legend Biotech position peaked at $4.28M in Q4 2021.
  • 141 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2022.

Based on California Public Employees Retirement System's 13F filing for Q1 2022, filed 4 May 2022.